Senate clears way for von Eschenbach vote

Share this article:
The US Senate today voted to end debate on the nomination of Andrew von Eschenbach to permanently head the FDA, clearing the way for a final vote. Von Eschenbach supporters overcame objections from three Republican senators who opposed his nomination. In a procedural move, the Senate voted, 89-6, to end debate over the nomination. A Senate vote to confirm von Eschenbach as FDA commissioner was expected later today, Reuters reported. Von Eschenbach has served as acting FDA commissioner since September 2005. He was nominated earlier this year by President Bush to take the job permanently.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.